Breaking News
Sort by:
Top Post
NHS Slashes Longest Elective and Cancer Patient Waiting Lists
The number of people waiting over 18 months for NHS care has fallen again despite […]
New Study: Decentralized Clinical Trials Can Achieve Net Financial Benefits of 5X to 14X, Due to Reduced Trial Timelines and Other Factors
Medable Inc., the leading cloud platform for patient-centered drug development, today announced results from a […]
Medable Secures $304 Million in Funding at $2.1 Billion Valuation; New Round Co-Led by Blackstone Growth, GSR Ventures, and Tiger Global
Medable Inc., the leading cloud platform for patient-centered clinical research, today announced $304 million in Series […]
Medable Hires Chief Strategy Officer to Expand Global Partner and Innovation Ecosystem for Decentralized Clinical Trials
Medable Inc., the leading cloud platform for patient-centered drug development, today announced the hiring of Dr. […]
Medable Opens New EMEA Headquarters in Dublin; Expands European Presence to Grow Market for Decentralized Clinical Trials
Medable Inc., the leading cloud platform for patient-centered drug development, today announced the first stage […]
Medable Launches Digital Certification Program to Accelerate Adoption of Decentralized Clinical Trials
Medable Inc., the leading software platform for patient-centered drug development, today announced an industry-first digital certification […]
Medable Hires Sanskriti Thakur as Chief Growth Officer to Lead Market Expansion
Medable Inc., the leading cloud platform for patient-centered drug development, today announced the hiring of Sanskriti […]
Syneos Health Partners with Medable, Expanding Decentralized Solutions to Bring Clinical Trials Closer to the Patient
Syneos Health®, the only fully integrated biopharmaceutical solutions organization, and Medable, the leading cloud platform […]
Medable Secures Another $78 Million Funding to Fuel Digital Innovation for Patient-Centered Drug Development
Medable Inc. today announced $78 million in new funding to fuel advances in the delivery […]
- Glyscend Therapeutics Appoints Biotech Industry Veteran Michael Wyzga to its Board of Directors Read more
- Trobix Bio Raises $3 Million from Chartered Group to Advance Precision Microbiome Oncology Therapeutics Read more
- Mathai Mammen to Join FogPharma as Chairman, President and Chief Executive Officer Read more
- Confo Therapeutics Enters into Collaboration Agreement with Daiichi Sankyo to Discover Novel Medicines for CNS Diseases Read more
- Implantica Launches RefluxStop™ in Italy Read more